Rare is not rare. On #RareDiseaseDay, we'd like to help raise awareness of the > 300 million people worldwide living with a rare disease, along with their families and carers. @rarediseaseday @RareDiseasesIE @RareDiseases
ATXA Therapeutics
@ATXA_Ireland
Innovating Cardiopulmonary Disease Treatment
205 Following 126 Followers 221 Posts
Latest posts 5
We are proud to announce that a new collaborative research article involving ATXA Therapeutics and our partners at Trinity College Dublin has been published this week in Nature Communications.
Read the full article here: nature.com/articles/s4146….
Read the full article here: nature.com/articles/s4146….
www.nature.com Structural and dynamic insights into agonist recognition and function of the thromboxane A2 receptor Nature Communications - The thromboxane A2 receptor (TP) is an important mediator of cardiovascular homeostasis. Here, authors report two structures of active TP-Gq bound to U46619 and I-BOP,... ATXA Therapeutics is looking forward to attending and presenting at the @PVRI Annual Congress 2026, taking place in Dublin, Ireland, from January 28 through February 1, 2026.
For more information, check out our website: atxatherapeutics.com/post/atxa-to-a…
For more information, check out our website: atxatherapeutics.com/post/atxa-to-a…
From all of us at ATXA Therapeutics, we wish you and yours a joyful and restful holiday season, and every success and happiness in 2026!
@ATXA_Ireland Founder & CEO Therese Kinsella is joining leading global, public and private companies from the biotechnology & pharmaceutical sectors at @Jefferies Global Healthcare Conference 2025 in London. Stay tuned for updates about the event with #JefferiesHealthcare
